Impaired T helper 2 response to aeroallergen in helminth-infected patients with asthma

被引:78
作者
Araujo, MIAS
Hoppe, B
Medeiros, M
Alcântara, L
Almeida, MC
Schriefer, A
Oliveira, RR
Kruschewsky, R
Figueiredo, JP
Cruz, AA
Carvalho, EM
机构
[1] Univ Fed Bahia, Hosp Univ Professor Edgard Santos, Serv Imunol, BR-40110160 Salvador, BA, Brazil
[2] Univ Fed Bahia, Fac Farm, BR-40110160 Salvador, BA, Brazil
[3] Univ Fed Bahia, Ctr Enfermidades Resp, BR-40110160 Salvador, BA, Brazil
[4] Escola Bahiana Med & Saude Publ, Salvador, BA, Brazil
[5] Conselho Nacl Desenvolvimento Cient & Tecnol, Inst Invest Imunol III, Salvador, BA, Brazil
[6] Cornell Univ, Weill Med Coll, Div Int Med & Infect Dis, New York, NY USA
关键词
D O I
10.1086/425017
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Helminthic infections have been shown to inhibit allergy skin-prick tests and to modify the course of asthma. We evaluated Dermatophagoides pteronyssinus-specific immune responses in patients with asthma by measuring levels of T helper 2 (Th2) cytokines in peripheral blood mononuclear cell (PBMC) cultures. PBMCs from Schistosoma mansoni-infected patients with asthma living in an area of polyhelminthic endemicity produced lower levels of interleukin (IL)-5 and IL-4 in response to D. pteronyssinus antigen (Ag) 1 than did PBMCs from helminth-free patients with asthma. In contrast, D. pteronyssinus Ag 1-specific production of IL-10 was higher in helminth-infected patients than in helminth-free patients. The addition of recombinant human IL-10 to D. pteronyssinus Ag 1-stimulated cultures of PBMCs from helminth-free patients led to down-modulation of production of IL-5. After helminth-infected patients with asthma received antihelminthic treatment, there was down-modulation of D. pteronyssinus Ag 1-specific production of IL-10 in vitro. S. mansoni infected patients with asthma produce lower levels of Th2 cytokines than do helminth-free patients with asthma, and this modulation is likely done by IL-10.
引用
收藏
页码:1797 / 1803
页数:7
相关论文
共 34 条
[1]   IL-10 induces a Th2 cell tolerance in allergic asthma [J].
Adachi, M ;
Oda, N ;
Kokubu, F ;
Minoguchi, K .
INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY, 1999, 118 (2-4) :391-394
[2]   Role of interleukin 10 in specific immunotherapy [J].
Akdis, CA ;
Blesken, T ;
Akdis, M ;
Wüthrich, B ;
Blaser, K .
JOURNAL OF CLINICAL INVESTIGATION, 1998, 102 (01) :98-106
[3]   Inverse association between skin response to aeroallergens and Schistosoma mansoni infection [J].
Araujo, MI ;
Lopes, AA ;
Medeiros, M ;
Cruz, AA ;
Sousa-Atta, L ;
Solé, D ;
Carvalho, EM .
INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY, 2000, 123 (02) :145-148
[4]   Evidence of a T helper type 2 activation in human schistosomiasis [J].
Araujo, MI ;
deJesus, AR ;
Bacellar, O ;
Sabin, E ;
Pearce, E ;
Carvalho, EM .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1996, 26 (06) :1399-1403
[5]   EXPOSURE AND SENSITIZATION TO DUST MITE ALLERGENS AMONG ASTHMATIC-CHILDREN IN SAO-PAULO, BRAZIL [J].
ARRUDA, LK ;
RIZZO, MC ;
CHAPMAN, MD ;
FERNANDEZCALDAS, E ;
BAGGIO, D ;
PLATTSMILLS, TAE ;
NASPITZ, CK .
CLINICAL AND EXPERIMENTAL ALLERGY, 1991, 21 (04) :433-439
[6]  
Asher MI, 1998, CLIN EXP ALLERGY, V28, P52
[7]  
BINA J C, 1987, Memorias do Instituto Oswaldo Cruz, V82, P331, DOI 10.1590/S0074-02761987000800062
[8]   Reversibility of Schistosoma mansoni-associated morbidity after yearly mass praziquantel therapy:: ultrasonographic assessment [J].
Boisier, P ;
Ramarokoto, CE ;
Ravaoalimalala, VE ;
Rabarijaona, L ;
Serieye, J ;
Esterre, P .
TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE, 1998, 92 (04) :451-453
[9]   Interleukin-10 regulation in normal subjects and patients with asthma [J].
Borish, L ;
Aarons, A ;
Rumbyrt, J ;
Cvietusa, P ;
Negri, J ;
Wenzel, S .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1996, 97 (06) :1288-1296
[10]  
Butterworth AE, 1998, BRIT MED BULL, V54, P357, DOI 10.1093/oxfordjournals.bmb.a011693